Avid Bioservices Inc (CDMO)

[biopharm]

I never knew that Tesaro was a main competitor of AstraZeneca (that called Peregrine their partner) and Peregrine mentioned them as having a collaboration....

Anyhow....Peregrine ex Medical Director Vladimir has a relative that is also Medical Director over at Tesaro

Speaking of Tesaro, Tesaro, Incyte and Juno sponsoring this Jan 2018 conference....that Peregrine collaborator MSKs Dr Jedd Wolchok (scientific organizer at event) will be presenting .....(wonder which combos he will discuss and this is exactly why Ronin group must not halt PS Targeting with Dr Wolchok or MSK or NCCN or others....

ASK Stephen White / Ronin group to not halt PS Targeting activity because it is possible that any unfinished data that is maturing may not reach publication or symposiums such as below in 5 months. Why the hell does Ronin group not file with SEC to legally back up what Peregrine investors want?? Any collaborations with Dr Jedd Wolchok ...MSK .NCCN etc must stay active or does Ronin group have an agenda to cancel these collaborations ???

T Cell Dysfunction, Cancer and Infection (A3)

Scientific Organizers: Daniel C. Douek, W. Nicholas Haining and Jedd D. Wolchok

January 16—20, 2018
Beaver Run Resort, Breckenridge, Colorado, USA

Sponsored by Incyte Corporation, Juno Therapeutics and TESARO, Inc.

...
...

Philip D. Greenberg, University of Washington, USA
Novel Approaches to Isolating Receptors and Engineering Cells to Target Tumor Antigens

...
...

Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center, USA
Clinical Results of Combined Checkpoint Blockades
...

https://www.keystonesymposia.org/index.cfm?e=web.Meeting.Program&meetingid=1545